Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV

Virology Journal

Volumn 8, Issue , 2011, Pages

  Khan, Najib U ^a   Ali, Ijaz ^a   Ahmad, Naeem U ^e   Iqbal, Aqib ^a   Rehman, Latif U ^a   Munir, Iqbal ^a   Rehman, Muti U ^b   Khan, Sanaullah ^c   Ali, Sajid ^d   Siddique, Lubna ^a   Swati, Zahoor A ^a  

^a THE UNIVERSITY OF AGRICULTURE   (Pakistan)

^b UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (Pakistan)

^c KOHAT UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Pakistan)

^d University of Pesawar   (Pakistan)

^e ISLAMIA COLLEGE UNIVERSITY   (Pakistan)

Author keywords

anti HCV; ELISA; immunochromatography; Pakistan; RT PCR

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; PAKISTAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; BLOOD; EVALUATION; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; STATISTICS; VIROLOGY;

HEPATITIS C VIRUS;

BLOOD DONORS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MASS SCREENING; PAKISTAN; PREVALENCE;

EID: 79953244193     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-154     Document Type: Article

References (17)

1. Sherris Medical Microbiology. KJ Ryan CG Ray, New York: McGraw Hill 2004 551 2
2. Genome of human hepatitis C virus (HCV), gene organization, sequence diversity, and variation. N Kato, Microb Comp Genomics 2000 5 3 129 51 11252351 (Pubitemid 32183233)
3. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BM Ajacio CF Sandra, BMC Gastroenterol 2002 2 18 10.1186/1471-230X-2-18 12169200
4. Diseases; Hepatitis C. WHO, http://www.who.int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index3.html [Accessed in 2011]
5. Hepatitis C assays: Operational characteristics (Phase I and Phase II) Report 1 & 2. WHO, 2001 WHO/BCT/BTS/01.5
6. Seroprevalence and risk factors of Hepatitis C virus (HCV) in Mardan, NWFP. MSA Khan M Khalid N Ayub M Javed, Rawal Med J 2004 29 57 60
7. Seroprevalence of HBsAg and anti-HCV in general healthy population of Swat district with frequency of different HCV Genotypes. A Ahmad B Ahmad A Ali Y Ahmad, Pak J Med Sci 2009 25 744 748
8. Anti-HCV in healthy voluntary blood donors in district swat. A Ahmed, JPMI 2006 20 187 90
9. Frequency of Hepatitis B and Hepatitis C in healthy blood donors of NWFP a single center experience. J Ahmad AS Taj A Rahim, J Postgrad Med Inst 2004 18 343 52
10. Factors influencing Hepatitis C virus sero-prevalence among blood donors in North West Pakistan. MN Khattak S Akhtar S Mahmud, J Public Health Policy 2008 29 207 25 10.1057/jphp.2008.7 18523475
11. Prevalence of hepatitis B surface antigen and hepatitis C antibodies in laboratory based data at Islamabad. AK Tanwani N Ahmed, J Surg 2000 19 25 9
12. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. SA Mujeeb MS Pearce, BMC Infect Dis 2008 8 43 10.1186/1471-2334-8-43 18402660
13. Seroprevalence of HBsAg and anti-HCV in healthy blood donors. ID Ujjan RA Memon AR Butt, Pak J Gastroenterol 2006 20 75 7
14. Frequency of hepatitis B surface antigen and anti-hepatitis C antibodies in apparently healthy blood donors in northern areas. M Alam MA Naeem, Pak J Pathol 2007 18 11 4
15. High rates of false-positive hepatitis C antibody tests can occur after left ventricular assist device implanation. AV Srivastava B Czerska C Williams I Alesh L Krese MA IIluang C Drost C Smith H Nemeh C Tita R Brewer D Lanfear, J Heart Lung Transplant 2009 28 159 160 10.1016/j.healun.2008.11.274
16. Unconfirmed reactive screening tests and their impact on donor management. M Rahman SA Khan Y Lodhi, Pak J Med Sci 2008 24 4 517 9
17. False-positive rapid tests for malaria in patients with rheumatoid factor. MP Grobusch U Alpermann S Schwenke T Jelinek DC Warhurst, Lancet 1999 353 297 10.1016/S0140-6736(05)74930-8 9929032 (Pubitemid 29088132)